This Confidential Private Placement Memorandum (the “Memorandum”) describes the private offering (the “Offering”) by Applied BioResearch, Inc., a Utah corporation, of a minimum of 25,000 shares (the “Minimum Offering”) and a maximum of 2,000,000 shares (the “Maximum Offering”) of common stock (the “Shares” or the “Securities”) at a price of $1.00 per Share (the “Offering Price”). The Company may increase the maximum of 2,000,000 shares, the Maximum Offering, at its sole discretion. The Company may also waive the minimum purchase requirement in its sole and absolute discretion. The Shares are being offered to an unlimited number of accredited investors only on a “best efforts” basis by its management personnel on the Company’s behalf. Subscription proceeds will be deposited directly into an account controlled by the Company. The Offering may be terminated upon the completion of the Maximum Offering.
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, (THE “ACT”) OR APPLICABLE STATE SECURITIES LAWS, NOR HAS THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) OR ANY STATE REGULATORY AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS MEMORANDUM OR ENDORSED THE MERITS OF THIS OFFERING AND REPRESENTATION TO THE CONTRARY IS UNLAWFUL